European Journal of Translational Myology is a premier, open access journal published by PAGEPRESS PUBL, dedicated to advancing research in the dynamic field of myology and its applications in various medical disciplines. Established in 2010, this journal disseminates crucial findings pertinent to translational myology, covering aspects within Cell Biology, Molecular Biology, Neurology, and Orthopedics and Sports Medicine. With a notable presence in the Scopus rankings and respectable quartiles across various categories, including Q3 positions in key areas as of 2023, the journal offers an invaluable platform for researchers and clinicians aiming to bridge the gap between experimental research and clinical practice. Located in Pavia, Italy, the journal welcomes contributions from scholars worldwide, fostering a collaborative environment that enhances knowledge exchange and encourages innovative approaches in myological research.

Neurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.

CURRENT OPINION IN NEUROLOGY is a premier academic journal dedicated to providing insightful overviews and critical analyses across all areas of neurology and clinical neurology. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an impressive impact factor, highlighting its influence and relevance in the field—positioning it in the Q1 category for both neurology and clinical neurology as of 2023. With its comprehensive coverage, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to stay abreast of the latest developments, trends, and breakthroughs in neurological science and practice. Though not open access, articles are available via institutional subscriptions or individual purchase, ensuring that vital research remains accessible to a wide audience. Covering research from its inception in 1993 to ongoing studies in 2024, CURRENT OPINION IN NEUROLOGY stands out as an essential platform for disseminating knowledge and fostering dialogue within the dynamic and evolving landscape of neurology.

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.

Degenerative Neurological and Neuromuscular Disease is a distinguished academic journal published by DOVE MEDICAL PRESS LTD, focusing on the latest advancements in the field of neurology and neuromuscular disorders. With a commitment to disseminating high-quality research, the journal aims to provide a critical platform for researchers, healthcare professionals, and students to share and engage with groundbreaking studies that advance our understanding of degenerative conditions affecting the nervous system. Although the journal's impact factor and h-index are currently not available, its open access model ensures that the valuable findings published within are accessible to a global audience, thereby fostering collaboration and innovation in neurological health. The journal's address is PO BOX 300-008, Albany, Auckland 0752, New Zealand, reflecting its international relevance and commitment to advancing the field of neurology. As the understanding of neurodegenerative diseases and neuromuscular challenges continues to evolve, Degenerative Neurological and Neuromuscular Disease serves as an essential resource for anyone dedicated to improving patient outcomes and advancing scientific knowledge.

DYSPHAGIA, published by Springer, is a premier journal dedicated to advancing the study of swallowing disorders, a critical area within the fields of Gastroenterology, Otorhinolaryngology, and Speech and Hearing. With an ISSN of 0179-051X and E-ISSN 1432-0460, this journal serves as a vital resource for researchers, clinicians, and students alike, providing cutting-edge research and reviews that inform clinical practice and enhance patient care. As a testament to its influence, DYSPHAGIA holds a Q2 ranking in Gastroenterology and Q1 rankings in both Otorhinolaryngology and Speech and Hearing for 2023. Its Scopus rankings further position it among the leading journals in its field, highlighting its importance and impact within the academic community. The journal publishes contributions that encompass a spectrum of topics related to swallowing, making it an essential platform for disseminating knowledge and fostering innovative solutions in the management of dysphagia. Operating from New York, NY, DYSPHAGIA invites contributions that align with its mission to advance the understanding and treatment of swallowing disorders through rigorous scientific inquiry and discourse.

Clinical Physiology and Functional Imaging, published by Wiley, is a distinguished journal dedicated to advancing the fields of clinical physiology and biomedical imaging. This UK-based publication, with an ISSN of 1475-0961 and an E-ISSN of 1475-097X, has established itself as an important resource for researchers and professionals from various backgrounds, focusing on the physiological mechanisms underlying human health and disease through innovative imaging techniques. With a convergence year span from 2002 to 2024, the journal is classified within the Q3 quartile across several medical and physiology categories in 2023, reflecting its commitment to quality research amid a competitive landscape. Although it currently lacks an H-index, its rankings within Scopus—#70 in Medicine (Miscellaneous) and #134 in Biochemistry, Genetics and Molecular Biology—underscore its relevance in a rapidly evolving field. Engaging with this journal offers an opportunity to explore emerging research that bridges clinical practice and advanced imaging modalities, making it an essential read for students and established professionals alike.

JOURNAL OF GENERAL PHYSIOLOGY, published by Rockefeller University Press, is a leading peer-reviewed journal that has been at the forefront of physiological research since its inception in 1918. With an ISSN of 0022-1295 and an E-ISSN of 1540-7748, this esteemed journal maintains an impressive Q1 ranking in the field of Physiology, reflecting its high-quality contributions to both the basic and applied aspects of physiology. Regularly cited in the scientific community, it ranks 70th out of 193 in the category of Biochemistry, Genetics, and Molecular Biology, showcasing its significant impact within academic circles. The journal publishes original research, reviews, and commentaries, aiming to advance the understanding of physiological mechanisms and their implications across various biological systems. Although not Open Access, the journal remains a vital resource for researchers, professionals, and students dedicated to exploring the depths of cardiopulmonary function, neurophysiology, and cellular biochemical processes. The JOURNAL OF GENERAL PHYSIOLOGY continues to serve as a critical platform for disseminating innovative findings and fostering collaboration among scientists globally.

ISOKINETICS AND EXERCISE SCIENCE, published by IOS PRESS, is a vital multidisciplinary journal that focuses on advancing research within the realms of biophysics, orthopedics, sports medicine, and rehabilitation sciences. With an ISSN of 0959-3020 and E-ISSN 1878-5913, this journal has been a cornerstone in the publication of pioneering studies from 1991 to 1998 and has continued its impactful presence from 2000 to 2024. Recognized for its contribution to the field, it holds a Q4 ranking in biophysics and Q3 in both orthopedics/sports medicine and physical therapy/sports therapy. The journal particularly caters to researchers, clinicians, and students by providing essential insights and updates in exercise science, facilitating a deeper understanding of the mechanics and benefits of isokinetic exercise. As the demand for evidence-based approaches in sports and rehabilitation grows, ISOKINETICS AND EXERCISE SCIENCE remains an indispensable resource for those dedicated to enhancing physical performance and health outcomes.

Journal of Neuromuscular Diseases, published by IOS PRESS, is a leading platform dedicated to advancing the field of neurology and neuromuscular research. With a focus on delivering high-quality, peer-reviewed content, this journal aims to foster knowledge sharing and collaboration among researchers, clinicians, and healthcare professionals dealing with neuromuscular disorders. The journal boasts a commendable impact factor within its respective categories, achieving Q2 rankings in both Neurology and Clinical Neurology as of 2023. Spanning from its inception in 2014 to the anticipated convergence in 2024, it is recognized for its contributions to critical discussions in the field, evidenced by its rankings of #145 out of 400 in clinical neurology and #75 out of 192 in neuroscience. As an open access journal, it facilitates wider accessibility of research findings, catering to an audience eager for innovative approaches and developments. Set against the backdrop of the vibrant academic scene in the Netherlands, the Journal of Neuromuscular Diseases serves as an essential resource for driving forward the boundaries of knowledge in neuromuscular-related conditions.